Funding for this research was provided by:
Ministero dell’Istruzione, dell’Università e della Ricerca (GR-2011-2347600)
Received: 18 December 2020
Accepted: 22 March 2021
First Online: 3 April 2021
: This study was performed in accordance with the Declaration of Helsinki, and was conducted after the acquisition of written informed consent from the participating patients and upon the approval by the ethics committee by the local Institutional Review Board of the University of Padua Medical Centre.
: If the manuscript is accepted, we approve it for publication in Cardiovascular Diabetology.
: AA received research grants, lecture or advisory board fees from Merck Sharp & Dome, AstraZeneca, Novartis, Boeringher-Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier, and Takeda, Neopharmed. PS received research grants, lecture or consultant or travel fees from CSL Behring, Stago, Werfen, Uniqure.